Keeping Current

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 289:56:06
  • More information

Informações:

Synopsis

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Episodes

  • Combination Therapy in COPD: What Are the Choices?

    25/11/2020 Duration: 34min

    Dr Usmani and colleagues discuss dual bronchodilation and triple therapy in the management of COPD, and how to choose the right inhaler. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939793?src=mkm_podcast_addon_939793

  • Evolving Paradigms in Myeloma Maintenance

    25/11/2020 Duration: 39min

    Drs Jackson, Chari, Dimopoulos, and Moreau discuss maintenance therapy for multiple myeloma in non-transplant and post-transplant settings. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/941374?src=mkm_podcast_addon_941374

  • Cardiometabolic Risk Control in Diabetes: Latest Insights and Recommendations

    16/11/2020 Duration: 21min

    Join Dr Subodh Verma and Dr David Strain as they discuss insights and recommendations from EASD 2020 for diabetes management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940593?src=mkm_podcast_addon_940593

  • Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Current and Future Perspectives

    12/11/2020 Duration: 50min

    Faculty panel moderated by Dr. Daniel Tan discusses the latest data on adjuvant use of EGFR TKIs in early-stage NSCLC. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940688?src=mkm_podcast_addon_940688

  • New Paradigms for Progressive Fibrosing Interstitial Lung Diseases

    11/11/2020 Duration: 39min

    Join Dr Vincent Cottin and Dr Fernando J. Martinez as they discuss patient management and novel therapeutic options. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940501?src=mkm_podcast_addon_940501

  • Exploring New Targets in the IL-23/IL-17 Pathway for Psoriasis

    10/11/2020 Duration: 26min

    Join Dr Gooderham as she covers why targeting IL-23 and IL-17 pathway is important in the management of psoriasis. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939580?src=mkm_podcast_addon_939580

  • The Present and Future of Next-Generation Insulins

    09/11/2020 Duration: 17min

    Join Dr Harpreet Bajaj as he discusses findings from trials with novel insulins in patients with T2DM presented at EASD 2020.  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/940178?src=mkm_podcast_addon_940178

  • A Call to Action for Improving Disease Control in Chronic Spontaneous Urticaria: From Guidelines to Clinical Practice

    29/10/2020 Duration: 36min

    Join our faculty as they discuss best practices in the management of patients with chronic spontaneous urticaria (CSU) Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939774?src=mkm_podcast_addon_939774

  • SGLT2 Inhibitor Treatment for HFrEF: Demonstrating Safety Beyond the Heart

    28/10/2020 Duration: 33min

    Using 2 cases, Drs Böhm and Marx discuss practical issues regarding the use of SGLT2 inhibitors in patients with HFrEF. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939634?src=mkm_podcast_addon_939634

  • CAR T-Cell Therapy in Lymphoma: Preparation, Communication, and Aftercare

    27/10/2020 Duration: 16min

    Join Dr Robinson as he provides guidance on identifying patients eligible for CAR T-cell therapy, as well as the management of the most common adverse events associated with CAR T-cell therapy. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939475?src=mkm_podcast_addon_939475

  • IVT Anti-VEGF Therapy: Practical Strategies to Protect Vision and Mitigate Risks

    27/10/2020 Duration: 32min

    Drs Kaiser and Baumel discuss recent data and share insights into recent efficacy and safety data using anti-VEGF therapies Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939610?src=mkm_podcast_addon_939610

  • Addressing Key Challenges and Unmet Needs in GPP Management

    27/10/2020 Duration: 16min

    Join our expert faculty as they discuss recognition and importance of rapid and effective treatment to minimize complications in GPP. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939538?src=mkm_podcast_addon_939538

  • A Case-Based Approach to Early Intervention in Schizophrenia: Optimizing Service Provision

    26/10/2020 Duration: 01h16min

    In this virtual symposium, Dr Kane and experts discuss a patient case vignette and optimal approaches to managing schizophrenia early on.  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939479?src=mkm_podcast_addon_939479

  • Cardiometabolic Risk Management With Glucose-Lowering Drugs: Essential News for the Cardiologist

    19/10/2020 Duration: 18min

    Join Drs Kim Connelly and Ulf Landmesser as they discuss the latest updates in cardiometabolic risk management from ESC 2020.  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_[ArticleID]

  • Understanding the Immunopathogenesis of CKD-Associated Pruritus

    13/10/2020 Duration: 28min

    Dr Szepietowski reviews the pathophysiology of CKD-aP and treatment strategies to improve symptoms and quality of life. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/938339?src=mkm_podcast_addon_938339

  • Catching and Managing Progressive Fibrosing Interstitial Lung Disease Progression Earlier

    13/10/2020 Duration: 52min

    Join our expert faculty as they discuss interstitial lung diseases (ILDs), importance of early recognition and optimal treatment options. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/938826?src=mkm_podcast_addon_938826

  • Latest Insights into CV Risk Reduction with GLP-1 RAs

    30/09/2020 Duration: 17min

    What’s new in CV risk reduction for people with diabetes? Dr Mark Petrie discusses key data from ESC 2020. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/937973?src=mkm_podcast_addon_937973

  • CAR T Cells in B-Cell Lymphoma: Implications of New Data and New Therapy

    17/09/2020 Duration: 40min

    Join Drs Abramson, Kersten, and Vitolo and get up to date on the highlights of the current and emerging CAR T-cell therapies in B-cell lymphomas. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/936699?src=mkm_podcast_addon_936699

  • What Are the Effects of SGLT2 Inhibitors In Patients With HFrEF?

    16/09/2020 Duration: 34min

    Dr Butler reviews the latest data on the use of SGLT2 inhibitors in HFrEF management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/937024?src=mkm_podcast_addon_937024

  • Optimizing Bronchodilator Therapy in COPD

    16/09/2020 Duration: 36min

    Dr Martinez and colleagues discuss the importance of early diagnosis of COPD and how bronchodilation therapy can be optimized. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934222?src=mkm_podcast_addon_934222

page 23 from 27